Saliva Detection Reagent Pre-Treatment for Non-Specific POD Reactions

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Non-specific reactions occur during the detection of substances in saliva samples using peroxidase-labeled reagents, leading to inaccurate results.

Innovation Solution

The use of glycoproteins like lactoferrin or transferrin, or iron-binding proteins like ferritin, is applied to saliva samples before the peroxidase-labeled Substance 1 contacts the target substance, to inactivate POD-like substances and reduce non-specific reactions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If peroxidase-labeled reagents are used to detect substances in saliva samples, then detection sensitivity is improved, but non-specific reactions increase leading to inaccurate results

Engineering Contradiction:
Improvedetection accuracyVSAvoidnon-specific reactions
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent introduces POD-inhibiting substances (such as phenolic compounds, flavonoids, or their derivatives) as intermediary agents that selectively inhibit POD-like substances in saliva samples. These intermediaries bind to or complex with the POD-like substances, preventing them from reacting with peroxidase-labeled reagents, while not interfering with the specific antigen-antibody detection process. This resolves the contradiction by filtering out harmful non-specific reactions while preserving detection accuracy.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent applies preliminary anti-action by adding POD-inhibiting substances to the saliva sample before the detection process begins. This pre-treatment step proactively neutralizes POD-like substances in advance, preventing them from causing non-specific reactions during subsequent peroxidase-based detection. The inhibiting substances are introduced early in the workflow to counteract the harmful effect before it can manifest, thereby maintaining measurement precision without sacrificing detection sensitivity.

Inventive Principle:
Principle #9Preliminary anti-action

2Ease of operation

If saliva samples are used for detection, then ease of collection and less invasiveness are improved, but presence of POD-like substances causes non-specific reactions

Engineering Contradiction:
Improveease of collectionVSAvoidPOD-like substance interference
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The patent employs POD-inhibiting substances as mediators that are added to saliva samples during the detection process. These intermediaries specifically target and inhibit POD-like substances endogenously present in saliva, such as dietary peroxidases or plant-derived peroxidases, without interfering with the detection of target analytes. This allows the continued use of easy-to-collect saliva samples while eliminating the harmful interference from their natural composition.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the chemical parameters of the saliva sample by introducing POD-inhibiting substances that change the redox environment or binding characteristics of POD-like substances. By altering these chemical parameters through the addition of phenolic compounds, flavonoids, or their derivatives, the patent transforms the sample properties to prevent non-specific peroxidase reactions while maintaining the integrity of the target analyte detection.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly reduces non-specific reactions, enhancing the accuracy of saliva-based detection methods by suppressing the activity of POD-like substances and improving the reliability of the detection process.

Implementation Method 1

The use of glycoproteins like lactoferrin or transferrin, or iron-binding proteins like ferritin, is applied to saliva samples before the peroxidase-labeled Substance 1 contacts the target substance, to inactivate POD-like substances and reduce non-specific reactions

Methodology Applied
Scientific EffectIron-binding: Adsorption

Data Source

PatentUS20260023078A1Reagent, kit, and method for detecting substance to be measured
Publication Date: 2026.01.22 FUJIFILM CORP
  • US20260023078A1 patent drawing
  • US20260023078A1 patent drawing

AI summary

An object of the present invention is to provide a reagent capable of reducing a non-specific reaction in the detection of a substance to be measured in a saliva sample using Substance 1 that is labeled with a peroxidase and that binds to the substance to be measured, a kit including the reagent, and a method for measuring a substance to be measured using the reagent. According to the present invention, there are provided a reagent containing a glycoprotein, in which, in detection of a substance to be measured in a saliva sample using Substance 1 that is labeled with peroxidase and binds to the substance to be measured, the reagent is a reagent for being brought into contact with the saliva sample prior to contact between the Substance 1 and the substance to be measured; a kit containing the reagent; and a method for measuring of a substance to be measured using the reagent.